Document is current
Any future updates will be listed below
-
Authors
Premeaux, Thomas A. https://orcid.org/0000-0002-2103-3421
Yeung, Stephen T.
Pillai, Satish K.
Ndhlovu, Lishomwa C.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01-MH112457)
- License Information
-
More Information
Article History
Received: 15 July 2022
Revised: 16 April 2023
Accepted: 11 May 2023
First Online: 26 May 2023
Declarations
:
: NNTC studies were conducted in accordance with human subject protection protocols at participating institutions. Written consent was obtained for subjects at four collection sites in the USA. The following offices maintained the institutional review boards (IRBs) that provided oversight for the protection of human subjects: (1) The University of Texas Medical Branch Office of Research Subject Protections; (2) Mount Sinai Medical Center Program for the Protection of Human Subjects; (3) University of California, San Diego Human Research Protections Program; (4) University of California, Los Angeles Office of the Human Research Protection Program.
: LCN reports grants from the NIH and has received consulting fees from work as a scientific advisor for AbbVie, ViiV Healthcare, and Cytodyn where he also serves on the Board of Directors for work outside of the submitted work. LCN interests were reviewed and are managed by Weill Cornell Medicine in accordance with their conflict-of-interest policies. All other authors declare that they have no conflict of interest.
